ArticleHeliyon2022

Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease.

Fadia Mayyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.